Your browser doesn't support javascript.
loading
Preliminary audiologic and peri-operative outcomes of the Sophono™ transcutaneous bone conduction device: A systematic review.
Bezdjian, Aren; Bruijnzeel, Hanneke; Daniel, Sam J; Grolman, Wilko; Thomeer, Hans G X M.
Afiliación
  • Bezdjian A; Department of Experimental Surgery, McGill University, Montreal, Quebec, Canada; McGill Auditory Sciences Lab, McGill University Health Centre Research Institute, Montreal, Quebec, Canada; Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Centre Utrecht, Utrecht, The Neth
  • Bruijnzeel H; Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands; Brain Centre Rudolf Magnus, Utrecht, The Netherlands.
  • Daniel SJ; McGill Auditory Sciences Lab, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.
  • Grolman W; Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Thomeer HGXM; Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.
Int J Pediatr Otorhinolaryngol ; 101: 196-203, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28964294
ABSTRACT

OBJECTIVE:

To delineate the auditory functional improvement and peri-operative outcomes of the Sophono™ transcutaneous bone conduction device.

METHODS:

Eligible articles presenting patients implanted with the Sophono™ were identified through a comprehensive search of PubMed and Embase electronic databases. All relevant articles were reviewed to justify inclusion independently by 2 authors. Studies that successfully passed critical appraisal for directness of evidence and risk of bias were included.

RESULTS:

From a total of 125 articles, 8 studies encompassing 86 patients using 99 implants were selected. Most patients (79.1%) were children. Ear atresia (67.5%) was the most frequently reported indication for Sophono™ implantation. Overall pure tone average auditory improvement was 31.10 (±8.29) decibel. During a mean follow-up time of 12.48 months, 25 patients (29%) presented with post-operative complications from which 3 were deemed as serious implant-related adverse events (3.5%).

CONCLUSIONS:

The Sophono™ transcutaneous bone conduction device shows promising functional improvement, no intra-operative complications and minor post-operative skin related complications. If suitable, the device could be a proposed solution for the rehabilitation of hearing in children meeting eligibility criteria. A wearing schedule must be implemented in order to reduce magnet-related skin complications.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Conducción Ósea / Audífonos / Pérdida Auditiva Conductiva Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Child / Female / Humans / Male Idioma: En Revista: Int J Pediatr Otorhinolaryngol Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Conducción Ósea / Audífonos / Pérdida Auditiva Conductiva Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Child / Female / Humans / Male Idioma: En Revista: Int J Pediatr Otorhinolaryngol Año: 2017 Tipo del documento: Article